Search Results for citation:"86 FR 11558"

Found 2 results
Skip to main content

Search Results: citation:"86 FR 11558"

  • Type:Notice
    Citation:86 FR 11558
    Reading Time:about a minute or two

    S&B Pharma, Inc. has applied to the Drug Enforcement Administration to be registered as a bulk manufacturer of certain controlled substances. The company intends to produce these substances in large quantities for product development and commercial sales. Specifically, S&B Pharma plans to create synthetic versions of Marihuana and Tetrahydrocannabinols. The public and current registered manufacturers have until April 26, 2021, to submit comments or request a hearing on this application.

    Simple Explanation

    S&B Pharma, Inc. wants permission from the government to make lots of special drugs called controlled substances, like fake versions of marijuana. People can tell the government what they think about this plan before April 26, 2021.

  • Type:Notice
    Citation:86 FR 11558
    Reading Time:about a minute or two

    Myonex Inc has applied for registration as an importer of specific controlled substances, according to a notice from the Drug Enforcement Administration (DEA). The substances are intended for use in clinical trials, research, and analytical purposes, and not for commercial sale of finished dosage forms. Interested parties have until March 29, 2021, to submit written comments or objections, or to request a hearing regarding this application. Written submissions should be directed to the DEA at their office in Springfield, Virginia.

    Simple Explanation

    Myonex Inc wants to bring in some special medicines from other countries to use in experiments and tests but not to sell them in stores. If anyone has questions or concerns, they can tell the people in charge by March 29, 2021.